AI/ML Innovations Inc. Welcomes Industry Veterans to Board of Directors
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) has announced significant changes to its Board of Directors. Mark Orsmond, a veteran healthcare executive with over 30 years of experience, has been appointed as Executive Chair. Orsmond's track record includes successfully developing and selling three healthcare businesses to Well Health Technologies Corp., and serving as CFO and Executive VP at Corix Group and ALL-SEA Group.
Michael Nemirow joins as Director, bringing extensive entrepreneurial experience, notably as CEO of Greenstar Plant Products, which he led to global expansion before its acquisition by a U.S. public company in 2021. The company has also granted stock options to a director for 250,000 shares at $0.17 per share, vesting quarterly over one year.
Tim Daniels will step down as Executive Chairman but remain on the Board. These appointments align with AIML's focus on AI and machine learning in digital health and wellbeing solutions.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) ha annunciato importanti cambiamenti nel suo Consiglio di Amministrazione. Mark Orsmond, un veterano del settore sanitario con oltre 30 anni di esperienza, è stato nominato Presidente Esecutivo. Il percorso professionale di Orsmond include lo sviluppo e la vendita con successo di tre aziende sanitarie a Well Health Technologies Corp., oltre a ricoprire i ruoli di CFO e VP Esecutivo presso Corix Group e ALL-SEA Group.
Michael Nemirow entra come Direttore, portando con sé una vasta esperienza imprenditoriale, in particolare come CEO di Greenstar Plant Products, che ha guidato verso l'espansione globale prima della sua acquisizione da parte di una società pubblica statunitense nel 2021. L'azienda ha anche concesso opzioni su azioni a un direttore per 250.000 azioni a $0,17 per azione, con scadenza trimestrale nell'arco di un anno.
Tim Daniels si dimetterà dalla carica di Presidente Esecutivo ma rimarrà nel Consiglio. Queste nomine si allineano con l'orientamento di AIML verso l'AI e l'apprendimento automatico nelle soluzioni di salute digitale e benessere.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) ha anunciado cambios significativos en su Junta Directiva. Mark Orsmond, un veterano ejecutivo del sector salud con más de 30 años de experiencia, ha sido nombrado Presidente Ejecutivo. El historial de Orsmond incluye el desarrollo y la venta exitosa de tres empresas de salud a Well Health Technologies Corp., además de haber servido como CFO y Vicepresidente Ejecutivo en Corix Group y ALL-SEA Group.
Michael Nemirow se une como Director, aportando una extensa experiencia empresarial, notablemente como CEO de Greenstar Plant Products, que llevó a una expansión global antes de su adquisición por una empresa pública de EE. UU. en 2021. La compañía también ha otorgado opciones sobre acciones a un director para 250,000 acciones a $0.17 por acción, que se vencerán trimestralmente durante un año.
Tim Daniels renunciará como Presidente Ejecutivo, pero permanecerá en la Junta. Estos nombramientos están alineados con el enfoque de AIML en la IA y el aprendizaje automático en soluciones de salud digital y bienestar.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)는 이사회에 중대한 변화를 발표했습니다. Mark Orsmond는 30년 이상의 경력을 가진 헬스케어 분야의 베테랑으로, 임원 의장으로 임명되었습니다. Orsmond는 Well Health Technologies Corp.에 세 개의 헬스케어 사업을 성공적으로 개발하고 판매한 경력을 포함하고 있으며, Corix Group과 ALL-SEA Group에서 CFO 및 임원 부사장으로 재직했습니다.
Michael Nemirow는 2021년 미국의 상장 기업에 인수되기 전 세계적인 확장을 이끌었던 Greenstar Plant Products의 CEO로서 폭넓은 기업 경험을 지닌 이사로 합류했습니다. 회사는 또한 이사에게 250,000주를 주당 $0.17에 제공하는 주식 옵션을 부여했으며, 이는 1년 동안 분기별로 발생됩니다.
Tim Daniels는 임원 의장직에서 물러나지만 여전히 이사회에 남아 있습니다. 이러한 임명은 디지털 건강 및 웰빙 솔루션에서 AI 및 머신러닝에 대한 AIML의 초점과 일치합니다.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) a annoncé des changements significatifs au sein de son Conseil d'Administration. Mark Orsmond, un vétéran du secteur de la santé avec plus de 30 ans d'expérience, a été nommé Président Exécutif. Le parcours d'Orsmond inclut le développement et la vente réussis de trois entreprises de santé à Well Health Technologies Corp., ainsi que des fonctions de directeur financier et vice-président exécutif chez Corix Group et ALL-SEA Group.
Michael Nemirow rejoint le Conseil en tant que Directeur, apportant une vaste expérience entrepreneuriale, notamment en tant que PDG de Greenstar Plant Products, qu'il a dirigé vers une expansion mondiale avant son acquisition par une entreprise publique américaine en 2021. La société a également accordé des options d'achat d'actions à un directeur pour 250 000 actions à 0,17 $ par action, avec des acquisitions trimestrielles sur un an.
Tim Daniels démissionnera de son poste de Président Exécutif mais restera au Conseil. Ces nominations sont en accord avec l'orientation d'AIML vers l'IA et l'apprentissage automatique dans les solutions de santé numérique et de bien-être.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) hat bedeutende Veränderungen in seinem Vorstand angekündigt. Mark Orsmond, ein Veteran im Gesundheitswesen mit über 30 Jahren Erfahrung, wurde zum Exekutivvorsitzenden ernannt. Orsmonds Erfolgsbilanz umfasst die erfolgreiche Entwicklung und den Verkauf von drei Gesundheitsunternehmen an Well Health Technologies Corp., und er diente als CFO und Executive VP bei Corix Group und ALL-SEA Group.
Michael Nemirow tritt als Direktor bei, bringt umfangreiche unternehmerische Erfahrung mit, insbesondere als CEO von Greenstar Plant Products, das er vor der Übernahme durch ein US-öffentliches Unternehmen im Jahr 2021 zu einer globalen Expansion führte. Das Unternehmen hat auch einem Direktor Aktienoptionen für 250.000 Aktien zu einem Preis von 0,17 $ pro Aktie gewährt, die über ein Jahr hinweg vierteljährlich übertragen werden.
Tim Daniels wird von seiner Position als Exekutivvorsitzender zurücktreten, bleibt aber im Vorstand. Diese Ernennungen stehen im Einklang mit AIMLs Fokus auf KI und maschinelles Lernen in digitalen Gesundheits- und Wohlfühl-Lösungen.
- Appointment of experienced healthcare executive Mark Orsmond as Executive Chair, bringing expertise in successful business exits
- Addition of Michael Nemirow as Director with proven track record in global business expansion and successful exit
- None.
Mark Orsmond, a highly respected business professional in Canadian Healthcare, Appointed Executive Chair
Michael Nemirow Joins as Director, Bringing Decades of Entrepreneurial Expertise
VANCOUVER, BC / ACCESSWIRE / January 9, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce the appointment of two distinguished leaders to its Board of Directors. Mark Orsmond, a highly respected pioneer among healthcare executives in Canada, joins as Executive Chair, while seasoned business entrepreneur Michael Nemirow steps into the role of Director.
Mark Orsmond has earned a reputation as a transformative leader in Canada, with a career spanning over 30 years. Mark has successfully developed and scaled multiple ventures, including three healthcare businesses that were sold to Well Health Technologies Corp. (TSX: WELL). His extensive experience includes serving as CFO and Executive Vice President at the Corix Group of Companies and the ALL-SEA Group of Companies. A holder of a B.Compt degree from the University of South Africa and a CPA designation, Mr. Orsmond's leadership has consistently driven organizational success and premier exits.
Michael Nemirow brings an entrepreneurial acumen honed over decades of scaling and transforming businesses across diverse industries. As CEO of Greenstar Plant Products, Inc., Mr. Nemirow led a strategic overhaul, streamlining operations, acquiring a complementary organic brand, and driving the company's global presence in markets such as North America, South America, Europe, and Australia. Under his leadership, Greenstar grew into a globally recognized manufacturer and was acquired by a public U.S. company in 2021.
"We are privileged to welcome two exceptional leaders to our Board," said Paul Duffy, CEO of AIML. "Mark Orsmond's unparalleled influence in Canadian healthcare and Michael Nemirow's entrepreneurial expertise will be invaluable as AIML accelerates its global expansion and innovation in health technology. Their strategic guidance will be a cornerstone of our future success."
The Company also extends its gratitude to Tim Daniels for his leadership as Executive Chairman. Mr. Daniels will remain a valued member of the Board.
Stock Options Grant
The Company further announces the grant of stock options to a director to purchase up to 250,000 common shares of the Company ("Shares") at an exercise price of
For more information about AIML:
For detailed information please see AIML's website or the Company's filed documents at www.sedarplus.ca.
For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com.
About AI/ML Innovations Inc. https://aiml-innovations.com/
AIML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence: (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through its acquisition of Quantum Sciences Ltd. (
On behalf of the Board of Directors
Tim Daniels, Director
The Canadian Securities Exchange has in no way passed upon the merits of the Company and has neither approved nor disapproved the contents of this press release. Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: AI/ML Innovations, Inc.
View the original press release on accesswire.com
FAQ
What changes were made to AIMLF's Board of Directors in January 2024?
What stock options did AIMLF grant in January 2024?
What is Mark Orsmond's background before joining AIMLF?
What is Michael Nemirow's business experience prior to AIMLF?
